Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Gilead broadens HIV expanded access program for Preveon

April 8, 1998

Ligand reports positive results of Panretin phase III trial

April 7, 1998

Novel HIV vaccine available for licensing from NIH

April 6, 1998

IND granted for Enzo Biochem's HGTV43 genetic antisense therapy for AIDS

April 3, 1998

Patient enrollment in Provir phase III trial begins

April 1, 1998

Viramune triple RT therapy provides sustained reduction in HIV-1 RNA to undetectable levels

March 31, 1998

DuPont Merck searches for orally active cyclic urea HIV protease inhibitors

March 31, 1998

AIDS vaccine technologies available for licensing from NIH

March 27, 1998

Incyte identifies human monocyte chemotactic proprotein

March 27, 1998

FDA to review data from phase III trial of Alferon N Injection in HIV

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...